Literature DB >> 29573871

Low back pain: a call for action.

Rachelle Buchbinder1, Maurits van Tulder2, Birgitta Öberg3, Lucíola Menezes Costa4, Anthony Woolf5, Mark Schoene6, Peter Croft7.   

Abstract

Low back pain is the leading worldwide cause of years lost to disability and its burden is growing alongside the increasing and ageing population.1 Because these population shifts are more rapid in low-income and middle-income countries, where adequate resources to address the problem might not exist, the effects will probably be more extreme in these regions. Most low back pain is unrelated to specific identifiable spinal abnormalities, and our Viewpoint, the third paper in this Lancet Series,2,3 is a call for action on this global problem of low back pain.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29573871     DOI: 10.1016/S0140-6736(18)30488-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  199 in total

1.  The catastrophization effects of an MRI report on the patient and surgeon and the benefits of 'clinical reporting': results from an RCT and blinded trials.

Authors:  S Rajasekaran; S Dilip Chand Raja; Bhari Thippeswamy Pushpa; Kumar Behera Ananda; Shetty Ajoy Prasad; Mugesh Kanna Rishi
Journal:  Eur Spine J       Date:  2021-03-21       Impact factor: 3.134

2.  Effect of Intensive Patient Education vs Placebo Patient Education on Outcomes in Patients With Acute Low Back Pain: A Randomized Clinical Trial.

Authors:  Adrian C Traeger; Hopin Lee; Markus Hübscher; Ian W Skinner; G Lorimer Moseley; Michael K Nicholas; Nicholas Henschke; Kathryn M Refshauge; Fiona M Blyth; Chris J Main; Julia M Hush; Serigne Lo; James H McAuley
Journal:  JAMA Neurol       Date:  2019-02-01       Impact factor: 18.302

3.  Does Capacitively Coupled Electric Fields Stimulation Improve Clinical Outcomes After Instrumented Spinal Fusion? A Multicentered Randomized, Prospective, Double-Blind, Placebo-Controlled Trial.

Authors:  Leo Massari; Giovanni Barbanti Brodano; Stefania Setti; Gaetano Caruso; Enrico Gallazzi; Simona Salati; Marco Brayda-Bruno
Journal:  Int J Spine Surg       Date:  2021-01-20

Review 4.  Controlling the burden of spinal disorders in low- and middle-income countries.

Authors:  Anthony D Woolf
Journal:  Eur Spine J       Date:  2018-08-27       Impact factor: 3.134

Review 5.  [Pain medications for acute and chronic low back pain].

Authors:  M M Wertli; J Steurer
Journal:  Internist (Berl)       Date:  2018-11       Impact factor: 0.743

Review 6.  Journal impact factor is associated with PRISMA endorsement, but not with the methodological quality of low back pain systematic reviews: a methodological review.

Authors:  Dafne Port Nascimento; Gabrielle Zoldan Gonzalez; Amanda Costa Araujo; Leonardo Oliveira Pena Costa
Journal:  Eur Spine J       Date:  2019-11-09       Impact factor: 3.134

7.  Health-care utilisation for low back pain: a systematic review and meta-analysis of population-based observational studies.

Authors:  Getahun Kebede Beyera; Jane O'Brien; Steven Campbell
Journal:  Rheumatol Int       Date:  2019-08-28       Impact factor: 2.631

8.  Description of low back pain clinical trials in physical therapy: a cross sectional study.

Authors:  Dafne Port Nascimento; Gabrielle Zoldan Gonzalez; Amanda Costa Araujo; Leonardo Oliveira Pena Costa
Journal:  Braz J Phys Ther       Date:  2018-09-13       Impact factor: 3.377

9.  Bacteria: back pain, leg pain and Modic sign-a surgical multicentre comparative study.

Authors:  Peter Fritzell; Christina Welinder-Olsson; Bodil Jönsson; Åsa Melhus; Siv G E Andersson; Tomas Bergström; Hans Tropp; Paul Gerdhem; Olle Hägg; Hans Laestander; Björn Knutsson; Anders Lundin; Per Ekman; Eric Rydman; Mikael Skorpil
Journal:  Eur Spine J       Date:  2019-10-01       Impact factor: 3.134

10.  Deep Learning-Based Automatic Segmentation of Lumbosacral Nerves on CT for Spinal Intervention: A Translational Study.

Authors:  G Fan; H Liu; Z Wu; Y Li; C Feng; D Wang; J Luo; W M Wells; S He
Journal:  AJNR Am J Neuroradiol       Date:  2019-05-30       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.